Page 332 - parasitology for medical and clinical laboratoryprofessionals

312 INDEX

malaise, 234 symptoms, 72 nematodes, 9. See also helminths
malaria, 6, 9, 83–88, 116 treatment and prevention, 73 Ascaris lumbricoides, 139–142
causes of, 23–24 Middle Ages, 11–12 Brugia malayi, 105–107
comparison of babesiosis and, 236–237 miracidia, 129, 131, 184 Brugia timori, 97, 100, 103–105
confusion with cutaneous miracidium, 128 definition of, 136
Leishmania, 80 mites, 6, 216–219, 225 dracunculiasis and, 108
disease transmission, 86 mitochondrionlike organelles, 58 Enterobius vermicularis, 137–139
history/overview of, 83–85 Miyairi, Keinosuke, 194 history of hookworm infections,
laboratory diagnosis, 86–87 mollusks, 128, 182 122–123
life cycle, 85–86, 280 molt, 216 hookworm infections in United States,
morphology, 85 monocytes, 82 123–125
symptoms, 85 mononucleosis, 234 hookworms, 121–125
treatment and prevention, 87–88 Montenegro (Leishmania) skin test, 83 intestinal, 135–159
treatment for, 24 mortality, 254 life cycle, 97, 102
malarial stippling, 274 mosquitoes, 6, 12 lymphatic filariasis and, 96–107
mandibles, 228 Aedes, 9, 107 Mansonella ozzardi, 114
mange, 217 Anopheles, 9, 24, 85–87, 107 Mansonella perstans, 114
Manson, Patrick, 12, 87, 100–101, Brugia malayi and, 105–106 Onchocerca volvulus, 111
190, 194 culicine, 87 pinworms, 136–139
Manson-Bahr, Philip E. C., 81 eradication of, 105 Toxoplasma gondii, 89
Mansonella ozzardi, 114–115 filariasis and, 101 Trichinella spiralis, 201
Mansonella perstans, 115 malaria and, 24, 85 Wuchereria bancrofti, 103–104
Mansonella streptocerca, 113–114 Mansonia, 105, 107 Neorickettsia sennetsu, 241
Mansonia mosquito, 105, 107 mucocutaneous, 80 neurocysticercosis, 162–163
mature proglottids (“segments”), 163 mucosa examinations, 25 neutrophil, 241
meningoencephalitis, 273 multicellular, 37 New England Journal of Medicine, 248
mesenteric veins, 131 multivesicular, 208 New York Times, 8
mesocercaria, 128 mutualism, 3 NHANES (National Health and
metacercaria, 128, 182 myalgia, 79, 116 Nutritional Examination
Metagonimus yokogawai, 184–186 myeloproliferative disorders, 20 Survey), 88
disease transmission, 186 nonintestinal amobea, 66–67
laboratory diagnosis, 186 N normal intestinal flora, 20
life cycle, 185 Norwegian scabies, 217
morphology, 185 nagana, 95 nymphal stage, 219
overview of, 184–185 National Health and Nutritional nymphal ticks, 235
symptoms, 185 Examination Survey
treatment and prevention, 186 (NHANES). See NHANES O
metastasis, 209 (National Health and Nutritional
metazoan, 6 Examination Survey) “O&P” test, 25
methylene blue stain, 244 natural immunity, 255 obligate, 72
miasma, 85 Naunyn, Bernhard, 204 occult filariasis, 97
microbiology, 85 Necator americanus, 121–125, 132–133, ocular micrometer, 283
micro-crustacean copepod, 170 145–153, 157–158 ocular units, 283
microfilaremic, 97 differentiating from Strongyloides oculoglandular, 245
microfilaria, 27, 97 stercoralis, 153–154 Ohara’s fever. See tularemia
microscopes, calibration of, 283–284 disease transmission, 149–150 On the Nature and Treatment of Stomach
microsporidia, 72–73 laboratory diagnosis, 150 and Renal Diseases (Prout), 101
disease transmission, 72–73 life cycle, 147–149 Onchocerca volvulus, 111–112
laboratory diagnosis, 73 morphology, 145 onchocerciasis, 111
life cycle, 72 symptoms, 145–147 oncospheres, 163, 206
morphology, 72 treatment and prevention, 150–153 operculum, 166
overview of, 72 “negro lethargy,” 95 opisthorchiasis, 183